Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Strongbridge Bio Ord (SBBP)

Strongbridge Bio Ord (SBBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Strongbridge Bio Ord 900 NORTHBROOK DRIVE SUITE 200 TREVOSE PA 19053 USA

www.strongbridgebio.com P: 610-254-9200

Description:

Strongbridge Biopharma PLC is a biopharmaceutical company which develops, acquires and commercializes product candidates that target rare diseases. Its product candidate consists of COR-003, is a cortisol inhibitor, for the treatment of endogenous Cushing's syndrome, COR-004 and COR-005 to treat acromegaly, BP-2001, the treatment of diabetes which are in different clinical trial. Strongbridge Biopharma PLC is based in Trevose, Pennsylvania.

Key Statistics

Overview:

Market Capitalization, $K 135,658
Shares Outstanding, K 67,829
Annual Sales, $ 30,730 K
Annual Net Income, $ -45,080 K
Last Quarter Sales, $ 10,040 K
Last Quarter Net Income, $ -13,240 K
60-Month Beta 1.59
% of Insider Shareholders 5.10%
% of Institutional Shareholders 52.03%
Float, K 64,370
% Float 94.90%

Growth:

1-Year Return -7.41%
3-Year Return -60.00%
5-Year Return -60.08%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 70.23%
5-Year Dividend Growth 0.00%

Per-Share Information:

Latest Earnings Date 11/04/21
Earnings Per Share ttm -0.75
EPS Growth vs. Prev Qtr -16.67%
EPS Growth vs. Prev Year 34.38%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

SBBP Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -66.82%
Return-on-Assets % -36.21%
Profit Margin % -146.70%
Debt/Equity 0.38
Price/Sales 4.35
Price/Cash Flow N/A
Price/Book 3.06
Book Value/Share 0.65
Interest Coverage -32.65
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar